Hospital at home treatment with remdesivir for patients with COVID-19: real-life experience.

Authors:
Pereta I; Morancho A; López N; Ibáñez B; Salas C and 15 more

Journal:
Int J Infect Dis

Publication Year: 2022

DOI:
10.1016/j.ijid.2022.12.011

PMCID:
PMC9744477

PMID:
36521589

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Int J Infect Dis

Abbreviation: Int J Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
An ancient coronavirus from individuals in France, circa 16th century.
Oumarou Hama H; Chenal T; Pible O and 3 more (2023) - Transparency Score: 4/6
Assessing the utility of pregnant women as a sentinel surveillance population for malaria in Geita,…
Munsey A; Kinyina A; Assenga M and 12 more (2023) - Transparency Score: 3/6
Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneu…
Howard LM; Huang X; Chen W and 13 more (2023) - Transparency Score: 3/6
Autoantibodies against type I interferons in COVID-19 infection: A systematic review and meta-analy…
Wang X; Tang Q; Li H and 4 more (2023) - Transparency Score: 5/6
Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection.
Najafi-Fard S; Aiello A; Navarra A and 10 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations of competing interest The authors have no competing interests to declare."

Evidence found in paper:

"Funding This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Data have been generated as part of the routine work of the Hospital Clínic's Hospital at Home Unit."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025